Manhattan Atlantic Capital

What is Manhattan Atlantic Capital?

Manhattan Atlantic Capital (MAC) is a specialized healthcare private equity firm with a global presence, having offices in New York, London, and Johannesburg. They focus on both majority and minority investments in the healthcare sector, targeting mid-range capital opportunities.

Their investment spectrum covers various sub-sectors within healthcare including diagnostics, healthcare services, health insurance, pharmaceuticals, and medical technology. Through their investments, MAC is committed to fostering long-term value not just for their investors but also for the communities in which they operate.

They believe in the potential of the healthcare sector, citing that healthcare expenditure is likely to surpass GDP growth in the coming years based on OECD forecasts. The Economic Intelligence Unit noted consistent growth in the Brazilian healthcare sector, and McKinsey reported significant growth in the African Pharma market. Furthermore, MAC contends that sustainable, positive societal and environmental impacts can be harmonized with solid financial returns, and does not view environmental, social, and governance variables as being exclusive to favorable financial outcomes.

Their comprehensive investment strategy includes a diligent investment process, value creation, effective risk management, and strategic deal sourcing. Their professional team works to leverage industry insights to identify and cultivate opportunities that align with these beliefs and their healthcare focus.

Lastly, although their main focus is healthcare, they show an interest in the growth potential of the consumer private equity sector, highlighting sectors like food and beverages in the EU and Brazil as areas where growth outpaces GDP, providing further insight into their broader market interest and understanding.